Idiopathic Intracranial Hypertension is Associated with a Higher Burden of Visible Cerebral Perivascular Spaces: The Glymphatic Connection

References

1. 1.↵
   1. Markey KA,
   2. Mollan SP,
   3. Jensen RH, et al

   . Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol 2016;15:78–91 doi:10.1016/S1474-4422(15)00298-7 pmid:26700907

   CrossRefPubMed
2. 2.↵
   1. Wall M

   . Idiopathic intracranial hypertension. Neurol Clin 2010;28:593–617 doi:10.1016/j.ncl.2010.03.003 pmid:20637991

   CrossRefPubMed
3. 3.↵
   1. Bezerra MLS,
   2. Ferreira A,
   3. de Oliveira-Souza R

   . Pseudotumor cerebri and glymphatic dysfunction. Front Neurol 2017;8:734 doi:10.3389/fneur.2017.00734 pmid:29387036

   CrossRefPubMed
4. 4.↵
   1. Lenck S,
   2. Radovanovic I,
   3. Nicholson P, et al

   . Idiopathic intracranial hypertension: the veno glymphatic connections. Neurology 2018;91:515–22 doi:10.1212/WNL.0000000000006166 pmid:30201744

   Abstract/FREE Full Text
5. 5.↵
   1. Mangalore S,
   2. Rakshith S,
   3. Srinivasa R

   . Solving the riddle of “idiopathic” in idiopathic intracranial hypertension and normal pressure hydrocephalus: an imaging study of the possible mechanisms—Monro-Kellie 3.0. Asian J Neurosurg 2019;14:440–52 doi:10.4103/ajns.AJNS_252_18 pmid:31143260

   CrossRefPubMed
6. 6.↵
   1. Mollan SP,
   2. Ali F,
   3. Hassan-Smith G, et al

   . Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry 2016;87:982–92 doi:10.1136/jnnp-2015-311302 pmid:26888960

   Abstract/FREE Full Text
7. 7.↵
   1. Mondejar V,
   2. Patsalides A

   . The role of arachnoid granulations and the glymphatic system in the pathophysiology of idiopathic intracranial hypertension. Curr Neurol Neurosci Rep 2020;20:20 doi:10.1007/s11910-020-01044-4 pmid:32444998

   CrossRefPubMed
8. 8.↵
   1. Nicholson P,
   2. Kedra A,
   3. Shotar E, et al

   . Idiopathic intracranial hypertension: glymphedema of the brain. J Neuroophthalmol 2021;41:93–97 doi:10.1097/WNO.0000000000001000 pmid:33034442

   CrossRefPubMed
9. 9.↵
   1. Benveniste H,
   2. Lee H,
   3. Volkow ND

   . The glymphatic pathway: waste removal from the CNS via cerebrospinal fluid transport. Neuroscientist 2017;23:454–65 doi:10.1177/1073858417691030 pmid:28466758

   CrossRefPubMed
10. 10.↵
    1. Jessen NA,
    2. Munk AS,
    3. Lundgaard I, et al

    . The glymphatic system: a beginner’s guide. Neurochem Res 2015;40:2583–99 doi:10.1007/s11064-015-1581-6 pmid:25947369

    CrossRefPubMed
11. 11.↵
    1. Rehder D

    . Idiopathic intracranial hypertension: review of clinical syndrome, imaging findings, and treatment. Curr Probl Diagn Radiology 2020;49:205–14 doi:10.1067/j.cpradiol.2019.02.012 pmid:31056359

    CrossRefPubMed
12. 12.↵
    1. Morris PP,
    2. Black DF,
    3. Port J, et al

    . Transverse sinus stenosis is the most sensitive MR imaging correlate of idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2017;38:471–77 doi:10.3174/ajnr.A5055 pmid:28104635

    Abstract/FREE Full Text
13. 13.↵
    1. Friedman DI,
    2. Liu GT,
    3. Digre KB

    . Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013;81:1159–65 doi:10.1212/WNL.0b013e3182a55f17 pmid:23966248

    Abstract/FREE Full Text
14. 14.↵
    1. Boespflug EL,
    2. Simon MJ,
    3. Leonard E, et al

    . Targeted assessment of enlargement of the perivascular space in Alzheimer’s disease and vascular dementia subtypes implicates astroglial involvement specific to Alzheimer’s disease. J Alzheimers Dis 2018;66:1587–97 doi:10.3233/JAD-180367 pmid:30475760

    CrossRefPubMed
15. 15.↵
    1. Chabriat H,
    2. Joutel A,
    3. Dichgans M, et al

    . CADASIL. Lancet Neurol 2009;8:643–53 doi:10.1016/S1474-4422(09)70127-9 pmid:19539236

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Cordonnier C,
    2. Al-Shahi Salman R,
    3. Wardlaw J

    . Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007;130:1988–2003 doi:10.1093/brain/awl387 pmid:17322562

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Doubal FN,
    2. MacLullich AM,
    3. Ferguson KJ, et al

    . Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 2010;41:450–54 doi:10.1161/STROKEAHA.109.564914 pmid:20056930

    Abstract/FREE Full Text
18. 18.↵
    1. Granberg T,
    2. Moridi T,
    3. Brand JS, et al

    . Enlarged perivascular spaces in multiple sclerosis on magnetic resonance imaging: a systematic review and meta-analysis. J Neurol 2020;267:3199–3212 doi:10.1007/s00415-020-09971-5 pmid:32535680

    CrossRefPubMed
19. 19.↵
    1. Joutel A,
    2. Faraci FM

    . Cerebral small vessel disease: insights and opportunities from mouse models of collagen IV-related small-vessel disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 2014;45:1215–21 doi:10.1161/STROKEAHA.113.002878 pmid:24503668

    FREE Full Text
20. 20.↵
    1. Li Y,
    2. Zhu Z,
    3. Chen J, et al

    . Dilated perivascular space in the midbrain may reflect dopamine neuronal degeneration in Parkinson’s disease. Front Aging Neurosci 2020;12:161 doi:10.3389/fnagi.2020.00161 pmid:32581771

    CrossRefPubMed
21. 21.↵
    1. Louveau A,
    2. Da Mesquita S,
    3. Kipnis J

    . Lymphatics in neurological disorders: a neuro-lympho-vascular component of multiple sclerosis and Alzheimer’s disease? Neuron 2016;91:957–73 doi:10.1016/j.neuron.2016.08.027 pmid:27608759

    CrossRefPubMed
22. 22.↵
    1. Miyata M,
    2. Kakeda S,
    3. Iwata S, et al

    . Enlarged perivascular spaces are associated with the disease activity in systemic lupus erythematosus. Sci Rep 2017;7:12566 doi:10.1038/s41598-017-12966-4 pmid:28974720

    CrossRefPubMed
23. 23.↵
    1. Wardlaw JM,
    2. Smith C,
    3. Dichgans M

    . Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013;12:483–97 doi:10.1016/S1474-4422(13)70060-7 pmid:23602162

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Potter GM,
    2. Chappell FM,
    3. Morris Z, et al

    . Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability. Cerebrovasc Dis 2015;39:224–31 doi:10.1159/000375153 pmid:25823458

    CrossRefPubMed
25. 25.↵
    1. Mestre H,
    2. Kostrikov S,
    3. Mehta RI, et al

    . Perivascular spaces, glymphatic dysfunction, and small vessel disease. Clin Sci (Lond) 2017;131:2257–74 doi:10.1042/CS20160381 pmid:28798076

    Abstract/FREE Full Text
26. 26.↵
    1. Iliff JJ,
    2. Wang M,
    3. Liao Y, et al

    . A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 2012;4:147ra111 doi:10.1126/scitranslmed.3003748 pmid:22896675

    Abstract/FREE Full Text
27. 27.↵
    1. Yang L,
    2. Kress BT,
    3. Weber HJ, et al

    . Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer. J Transl Med 2013;11:107 doi:10.1186/1479-5876-11-107 pmid:23635358

    CrossRefPubMed
28. 28.↵
    1. Federico A,
    2. Di Donato I,
    3. Bianchi S, et al

    . Hereditary cerebral small vessel diseases: a review. J Neurol Sci 2012;322:25–30 doi:10.1016/j.jns.2012.07.041 pmid:22868088

    CrossRefPubMed
29. 29.↵
    1. Yamamoto Y,
    2. Ihara M,
    3. Tham C, et al

    . Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke 2009;40:2004–11 doi:10.1161/STROKEAHA.108.528299 pmid:19359623

    Abstract/FREE Full Text
30. 30.↵
    1. Yao M,
    2. Herve D,
    3. Jouvent E, et al

    . Dilated perivascular spaces in small-vessel disease: a study in CADASIL. Cerebrovasc Dis 2014;37:155–63 doi:10.1159/000356982 pmid:24503815

    CrossRefPubMed
31. 31.↵
    1. Loos CM,
    2. Klarenbeek P,
    3. van Oostenbrugge RJ, et al

    . Association between perivascular spaces and progression of white matter hyperintensities in lacunar stroke patients. PLoS One 2015;10:e0137323 doi:10.1371/journal.pone.0137323 pmid:26352265

    CrossRefPubMed
32. 32.↵
    1. Zhu YC,
    2. Tzourio C,
    3. Soumare A, et al

    . Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study. Stroke 2010;41:2483–90 doi:10.1161/STROKEAHA.110.591586 pmid:20864661

    Abstract/FREE Full Text
33. 33.↵
    1. Potter GM,
    2. Doubal FN,
    3. Jackson CA, et al

    . Enlarged perivascular spaces and cerebral small vessel disease. Int J Stroke 2015;10:376–81 doi:10.1111/ijs.12054 pmid:23692610

    CrossRefPubMed
34. 34.↵
    1. Sorensen PS,
    2. Thomsen C,
    3. Gjerris F, et al

    . Increased brain water content in pseudotumour cerebri measured by magnetic resonance imaging of brain water self-diffusion. Neurol Res 1989;11:160–64 doi:10.1080/01616412.1989.11739883 pmid:2573851

    CrossRefPubMed